Research Abstract
Human Study
Oral magnesium therapy was associated with a lower risk of heart failure hospitalization or death in patients with HF and hypomagnesemia.
Oral magnesium and outcomes in US veterans with heart failure.
Yancun Yin,
Rene Costello,
Gregg C Fonarow,
Paul A Heidenreich,
C Morgan,
Charles Faselis,
Yi-Yu Cheng,
A Zullo,
Su-Yuan Liu,
Paul Lam,
Andrea Rosanoff,
Jorge H Vargas,
Stephen S Gottlieb,
Prakash Deedwania,
Hannah C Moore,
Y Shao,
Helen M Sheriff,
Wan Wu,
Qing Zeng-Treitler,
Aftab Ahmed
Eur Heart J
Jan 5, 2026
Sources
AI Summary
Key Findings
0:00 / 0:00
0:00 / 0:00
Abstract
BACKGROUND AND AIMS: Magnesium deficiency is associated with poor outcomes in patients with heart failure (HF), but less is known about the impact of oral magnesium therapy. This study aimed to examine the association of oral magnesium with outcomes in patients with HF and whether it depends on baseline serum magnesium. METHODS: Of 54 696 Veterans with HF (2001-2023) and hypomagnesemia (serum magnesium
Affiliation
Ying Yin
External References
- PubMed ID:
- 41338273
Related Topics
Substance
Health Topic
Keyword
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.